FDA recall D-1099-2018

Product

Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.

Reason for recall

Defective Container: Customer complaints of punctures in the bottle.

Distribution

Nationwide in the USA

Key facts

Status

Terminated

Initiation date

2018-08-09

Report date

2018-08-22

Termination date

2019-11-15

Voluntary/Mandated

Voluntary: Firm initiated

Location

La Jolla, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1099-2018